DOCSLIB.ORG

Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Psoriasis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Psoriasis Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Psoriasis Chemical Activity Count (+)-ALPHA-VINIFERIN 3 (+)-CATECHIN 7 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 2 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 5 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 3 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 6 (-)-HYDROXYJASMONIC-ACID 2 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 3 (15:1)-CARDANOL 2 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (3'R,4'R)-3'-EPOXYANGELOYLOXY-4'-ACETOXY-3',4'-DIHYDROSESELIN 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 3 Chemical Activity Count 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 2 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 2 1,8-DIHYDROXY-9-ANTHRONE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 2 10-DEHYDROGINGERDIONE 2 10-GINGERDIONE 2 13',II8-BIAPIGENIN 3 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXYINGENOL-ESTER 1 2',6'-DIMETHOXY-4'-HYDROXYACETOPHENONE 2 2'-O-GLYCOSYLVITEXIN 1 2,3,7-TRIHYDROXY-5-(3,4-DIHYDROXY-E-STYRYL)-6,7,8,9-TETRAHYDRO-5H- 2 BENZOCYCLOHEPTENE 2,6-DIMETHOXYPHENOL 1 2-(3',4-DIPHENYL)-ETHANOL 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 3 2-CAFFEOYL-OXY-3-{2-(4-HYDROXYBENZYL)-4,5-DIHYDROXY}PHENYLPROPIONIC-ACID 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 1 3',4',5,7-TETRAHYDROXYFLAVONE 1 3,3'-DIMETHYLELLAGIC-ACID 1 3,4,5-TRI-O-CAFFEOYLQUINIC-ACID 1 3,4-DICAFFEOYL-QUINIC-ACID 1 2 Chemical Activity Count 3,4-DIHYDROXYBENZOATE 1 3,4-HYDROXYCINNAMIC-ACID 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3,5,6,7,8,3',4'-HEPTEMETHOXYFLAVONE 1 3,5,8,3',4'-PENTAHYDROXYFLAVONE 1 3,5-DI-O-CAFFEOYLQUINIC-ACID 2 3,5-DICAFFEOYL-QUINIC-ACID 2 3,7,8,2',5'-PENTAHYDROXYFLAVONE 1 3-ACETYLACONITINE 1 3-BETA-23,28-TRIHYDROXY-12-OLEANENE-23-CAFFEATE 1 3-BETA-23,28-TRIHYDROXY-12-OLEANENE-3-BETA-CAFFEATE 1 3-BETA-HYDROXY-2,3-DIHYDROWITHANOLIDE-F 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-20(29)-LUPEN-28-OIC-ACID 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-OLEAN-12-EN-28-OIC-ACID 1 3-BETA-TRANS-(3,4-DIHYDROXYCINNAMOYLOXY)-OLEAN-18-EN-28-OIC-ACID 1 3-HYDROXY-FLAVONE 3 3-N-BUTYL-PHTHALIDE 1 3-O-ACETYLOLEANOLIC-ACID 1 3-O-CAFFEOYLQUINIC-ACID 1 3-OXO-11-ALPHA-HYDROXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-11-ALPHA-METHOXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-OLEAN-9(11),12-DIENE-30-OIC-ACID 1 4,5-DI-O-CAFFEOYLQUINIC-ACID 1 4-ACETYLARABINOSYL-ELLAGIC-ACID 1 4-ACETYLXYLOSYL-ELLAGIC-ACID 1 4-ALLYL-PYROCATECHOL 1 3 Chemical Activity Count 4-AMINO-4-CARBOXYCHROMAN-2-ONE 1 4-ARABINOSYL-ELLAGIC-ACID 1 4-HYDROXY-TRITRIACONTANE-16,18-DIONE 1 4-HYDROXYCOUMARIN 1 4-KETOPINORESINOL 2 4-O-CAFFEOYLQUINIC-ACID 1 4-TERPINEOL 2 4-VINYL-GUAIACOL 3 5,7-DIHYDROXYCOUMARIN-7-METHYL-ETHER 1 5,7-DIMETHOXYFLAVONE 1 5,8-DIHYDROXYBENZOPYRANONE 2 5-DEOXYINGENOL-ESTER 1 5-HYDROXY-8-O-BETA-D-GLUCOPYRANOSYL-BENZOPYRANONE 2 5-METHOXY-PSORALEN 1 5-O-BETA-D-GLUCOPYRANOSYL-3-1-(4-PHENYL)-DECANE 1 5-O-CAFFEOYLQUINIC-ACID 1 6'-O-ACETYL-DAIDZIN 1 6'-O-ACETYL-GENISTIN 1 6,7,4'-TRIHYDROXYISOFLAVAN 1 6,7,4'-TRIHYDROXYISOFLAVANONE 1 6,7,4'-TRIHYDROXYISOFLAVONE 1 6,7-DI-4'-METHOXYISOFLAVAN 1 6,7-DI-4'-METHOXYISOFLAVANONE 1 6,7-DI-4'-METHOXYISOFLAVONE 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVAN 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVANONE 1 6,7-DIHYDROXY-4'-METHOXYISOFLAVONE 1 4 Chemical Activity Count 6,7-DIHYDROXYCOUMARIN 1 6,7-DIMETHYLAESCULETIN 1 6,7-DIMETHYLESCULETIN 1 6-DEHYDROGINGERDIONE 2 6-DEOXYJACAREUBIN 1 6-GINGERDIOL 1 6-GINGERDIONE 2 6-GINGEROL 4 6-O-(2''-ACETYL-3'',4''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-O-(4''-ACETYL-2'',3''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-SHOGAOL 3 7,8-DIHYDROXYFLAVONE 2 7-(4'-HYDROXY-3'-METHOXYPHENYL)-1,4-PHENYL-3,5-HEPTADIONE 1 7-HYDROXYCOUMARIN 1 7-METHOXYCOUMARIN 2 7-N-BUTOXY-3,2',5'-TRIHYDROXYFLAVONE 1 7-[3-(3,4-DIHYDROXY-4-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YLOXY)-4,5-DIHYDROXY-6- 2 HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY]... 8-ACETYLHARPAGIDE 1 8-METHOXY-PSORALEN 2 8-O-CINNAMOYLHARPAGIDE 1 9-HYDROXYELLIPTICINE 1 ABRINE 1 ACACETIN 1 ACANTHOIC-ACID 3 ACEMANNAN 1 ACETOXYPINORESINOL 1 ACETYL-11-KETO-BETA-BOSWELLIC-ACID 3 5 Chemical Activity Count ACETYL-BETA-BOSWELLIC-ACID 2 ACETYL-EUGENOL 2 ACETYLCURCUMIN 1 ACETYLSALICYLIC-ACID 1 ACETYLSHIKONIN 1 ACONITINE 1 ACTEOSIDE 1 ACTINIDIN 1 ACTINIDOLES 2 AESCIN 3 AESCULETIN 2 AESCULIN 4 AGRIMONIIN 1 AIPHANOL 1 AJOENE 7 ALANINE 1 ALANTOLACTONE 2 ALATERNIN 1 ALIZARIN 1 ALKANNIN 1 ALLANTOIN 4 ALLICIN 7 ALLIIN 2 ALLIXIN 1 ALLOPURINOL 1 ALLYL-MERCAPTAN 1 ALNUSIIN 1 6 Chemical Activity Count ALPHA-AMYRIN 2 ALPHA-AMYRIN-ACETATE 1 ALPHA-AMYRIN-PALMITATE 1 ALPHA-BISABOLOL 1 ALPHA-BOSWELLIC-ACID 5 ALPHA-CURCUMENE 1 ALPHA-CYPERONE 1 ALPHA-LINOLENIC-ACID 1 ALPHA-LIPOIC-ACID 1 ALPHA-PEROXYACHIFOLIDE 1 ALPHA-PINENE 1 ALPHA-SPINASTEROL 1 ALPHA-TERPINEOL 1 ALPHA-TOCOPHEROL 2 ALPHA-TOCOTRIENOL 1 AMENTOFLAVONE 4 AMPELOPSIN 1 AMYGDALIN 1 ANACARDIC-ACID 2 ANAGYRINE 1 ANDROGRAPHOLIDE 3 ANDROGRAPHOSIDE 2 ANETHOLE 3 ANISODAMINE 1 ANISOLE 1 ANNOMONTINE 1 ANTHOCYANIDINS 1 7 Chemical Activity Count ANTHOCYANINS 3 ANTHOCYANOSIDE 2 ANTHRAGALLOL 1 ANTHRANILIC-ACID 1 APIGENIN 6 APIGENIN-7-GLYCOSIDE 1 APIGENIN-7-O-GLUCOSIDE 1 APIGENIN-DIMETHYL-ETHER 1 APOCYNIN 2 APOMORPHINE 2 AR-TURMERONE 2 ARACHIDONIC-ACID 2 ARBORININE 1 ARBUTIN 1 ARDISIANONE 1 ARDISIAQUINONE 2 ARENARIOSIDE 1 ARISTOLOCHIC-ACID 3 ARNEBINONE 1 ARNICOLIDE 1 ARNICOLIDE-C 1 AROMATICIN 1 ARTABSIN 1 ARTECANIN 1 ARTEMETIN 2 ARTOCARPIN 1 ARVENOSIDE-A 1 8 Chemical Activity Count ASCORBIC-ACID 6 ASCORBYL-PALMITATE 1 ASIATICOSIDE 2 ASIMICIN 1 ASPALATHIN 1 ASPERULOSIDE 1 ASPIRIN 1 ASPIRIN (ACETYLSALICYLIC-ACID; NOT NATURAL) 1 ASTRAMEMBRANIN-I 1 ASTRINGENIN 3 ATRACTYLENOLIDE 1 ATRACTYLENOLIDE-I 1 ATRACTYLENOLIDE-II 1 ATRACTYLENOLIDE-III 1 ATRACTYLOCHROMENE 3 ATRACTYLON 2 AUCUBIN 3 AURAPTENE 1 AVENANTHRAMIDE-A 1 AVENANTHRAMIDE-B 1 AVENANTHRAMIDE-C 1 AVENANTHRAMIDE-D 1 AVENANTHRAMIDE-E 2 AVENANTHRAMIDES 1 AXILLARIN 1 AZELAIC-ACID 1 AZULENE 2 9 Chemical Activity Count BACOSIDE-A 1 BAICALEIN 8 BAICALEIN-5,6,7-TRIHYDROXY-FLAVONE 3 BAICALIN 5 BALLOTETROSIDE 1 BAOHUOSIDE-1 2 BARBATOSIDE-A 1 BARBATOSIDE-B 1 BARTSIOSIDE 1 BASSIC-ACID 1 BAVACHININ 2 BAYACHININE 1 BENZOXAZINOIDS 1 BENZOYLACONINE 1 BERBAMINE 4 BERBERASTINE 4 BERBERINE 5 BERGAPTEN 2 BERGENIN 1 BETA-AESCIN 2 BETA-AMYRIN 2 BETA-AMYRIN-ACETATE 2 BETA-BOSWELLIC-ACID 4 BETA-CAROTENE 4 BETA-D-TAGATOSE 1 BETA-DAMASCENONE 2 BETA-ESCIN 2 10 Chemical Activity Count BETA-HIMACHALINE 1 BETA-PINENE 1 BETA-SANTALENE 1 BETA-SITOSTEROL 4 BETA-SITOSTEROL-3-O-BETA-D-GLUCOPYRANOSIDE 1 BETA-TURMERONE 2 BETANIDIN 3 BETANIN 3 BETONICINE 1 BETULIN 1 BETULINIC-ACID 2 BIFLAVONES 2 BILOBALIDE 2 BILOBETIN 1 BIOTIN 1 BIS-(4-HYDROXY-CINNAMOYL)-METHANE 1 BIS-DEMETHOXYCURCUMIN 1 BIS-DESMETHOXYCURCUMIN 1 BISABOLOXIDE 1 BISEPOXYLIGNAN 1 BISMURRAYAFOLINE-E 1 BIXIN 1 BOEHMEROL-ACETATE 2 BOLDINE 5 BORJATRIOL 1 BORNEOL 1 BOSWELLIC-ACID 6 11 Chemical Activity Count BOWDICHIONE 1 BRADYKININASE 2 BRAZILIN 2 BREVIFOLIN 1 BROMELAIN 4 BROUSSOAURONE-A 2 BROUSSOCHALCONE-A 3 BROUSSOFLAVAN-A 1 BROUSSOFLAVONOL-F 2 BROUSSOFLAVONOL-G 1 BRUCINE 1 BRYONOLIC-ACID 2 BUDMUNCHIAMINES 1 BUPLEURIN 1 BUPLUERAN-2IIC 2 BUTEIN 2 BUTYL-PHTHALIDE 1 BUTYLIDENE-PHTHALIDE 2 CAFESTOL 1 CAFFEIC-ACID 9 CAFFEINE 2 CAFFEOYL-L-MALIC-ACID 1 CAFFEOYLMARIC-ACID 3 CAFFEOYLTARTARIC-ACID 3 CALCIUM 1 CALCIUM-CITRATE 1 CALOPHYLLIN-B 1 12 Chemical Activity Count CALOPHYLLOLIDE 1 CALOTROPIN 1 CAMPESTEROL 1 CAMPESTERYL-FERULATE 1 CAMPHENE 1 CAMPTOTHECIN 1 CANNABICHROMENE 1 CANNABIDIOL 1 CANNABIGEROL 1 CANNFLAVIN 2 CANNIPRENE 2 CAPSAICIN 3 CAPSAICINOL 1 CAPSANTHIN 1 CARBENOXOLONE 1 CARBOXYATRACTYLOSIDE 1 CARDOL 1 CARNOSIC-ACID 1 CARNOSINE 1 CARNOSOL 4 CARNOSOLIC-ACID 2 CARVACROL 5 CARVONE 1 CARYOPHYLLENE 3 CARYOPHYLLENE-OXIDE 2 CASUARININ 2 CATALASE 1 13 Chemical Activity Count CATECHIN 7 CATECHOL 1 CELESTROL 1 CEPAENE 2 CEPHARAMINE 1 CEPHARANOLINE 1 CEPHARANTHINE 6 CHAKSINE 1 CHAMAZULENE 4 CHEBULAGIC-ACID 1 CHEBULINIC-ACID 1 CHELERYTHRINE 2 CHICORIC-ACID 1 CHIKUSETSUSAPONIN 1 CHIKUSETSUSAPONIN-V 1 CHLOROGENIC-ACID 6 CHLOROGENIN 1 CHLOROPHORIN 1 CHLOROPHYLL 1 CHOLESTEROL 1 CHRYSANTHEMOL 1 CHRYSANTHENYL-ACETATE 1 CHRYSAROBIN 1 CHRYSAZIN 1 CHRYSIN 1 CHRYSIN-5,7-DIHYDROXYFLAVONE 1 CHRYSOERIOL 1 14 Chemical Activity Count CHRYSOSPLENIN 1 CHRYSOSPLENOL 1 CHYMOPAPAIN 1 CHYMOTRYPSIN 2 CICHORIC-ACID 1 CIMICIFUGIC-ACID-A 1 CIMICIFUGIC-ACID-B 1 CIMICIFUGIC-ACID-F 1 CIMIRACEMATE-A 1 CIMIRACEMATE-B 1 CINNAMALDEHYDE 4 CINNAMIC-ACID 2 CINNAMIC-ACID-BORNYL-ESTER 2 CINNCASSIOL 1 CIRSILINEOL 2 CIRSILIOL 2 CIRSIMARITIN 2 CIS-10-HEPTADECENOIC-ACID 1 CIS-10-NONADECENOIC-ACID 1 CIS-10-PENTADECENOIC-ACID 1 CIS-11,14-EICOSADIENOIC-ACID 1 CIS-11-EICOSENOIC-ACID 1 CIS-11-VACCENIC-ACID 1 CIS-13,16,19-DOCOSATRIENOIC-ACID 1 CIS-13,16-DOCOSADIENOIC-ACID 1 CIS-13-ERUCIC-ACID 1 CIS-15-NERVONIC-ACID 1 15 Chemical Activity Count CIS-8,11,14-EICOSATRIENOIC-ACID 1 CIS-9,12,15-LINOLENIC-ACID 1 CIS-9,12-LINOLEIC-ACID 1 CIS-9-OLEIC-ACID 1 CIS-9-PALMITOLEIC-ACID 1 CIS-COMMUNIC-ACID 1 CIS-METHYLSULPHINOTHIOIC-ACID-S-1-PROPENYLESTER 2 CIS-N-PROPYLSULPHINOTHIOIC-ACID-S-1-PROPENYLESTER 2 CIS-SPIROETHER
Load more

Recommended publications
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Lyme Disease (Chronic)
    Dr.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0105159 A1 Mccleary Et Al
    US 200301 05159A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0105159 A1 McCleary et al. (43) Pub. Date: Jun. 5, 2003 (54) KAVALACTONE COMPOSITIONS AND Publication Classification METHODS OF USE (51) Int. Cl." ....................... A61K 31/35; A61K 31/366; (76) Inventors: Joel McCleary, The Plains, VA (US); A61K 35/78; A61K 31/16 Peter S. Staats, Towson, MD (US) (52) U.S. Cl. ........................... 514/460; 514/625; 424/760 Correspondence Address: FISH & RICHARDSON PC 225 FRANKLIN ST BOSTON, MA 02110 (US) (57) ABSTRACT (21) Appl. No.: 10/214,624 (22) Filed: Aug. 8, 2002 This invention relates tO kavalactone-containing composi tions, and more particularly to compositions having com Related U.S. Application Data pounds derived from kavalactones and from capsaicinoids. The compositions are useful in modulating pain, and thus (60) Provisional application No. 60/311,437, filed on Aug. can be used to mediate, or eliminate, Sensations of pain, 10, 2001. thereby providing pain relief and reduction. US 2003/0105159 A1 Jun. 5, 2003 KAVALACTONE COMPOSITIONS AND METHODS 0006. In one embodiment, the invention relates to an OF USE analgesic topical composition having: (a) a kavalactone; (b) capsaicinoid or Synthetic derivatives thereof; and (c) a CROSS-REFERENCE TO RELATED pharmaceutically acceptable carrier; wherein the weight APPLICATIONS ratio of(a):(b) is from 5000:1 to 1:2 (e.g., 800:1 to 1:1; 500:1 to 5:1). In other aspects, the composition includes an effec 0001. This application claims benefit of U.S. application tive amount of kavalactones, active kavalactones, or capsai Ser.
    [Show full text]
  • Walnut Polyphenol
    ORYZA OIL & FAT CHEMICAL CO., L TD. WALNUT POLYPHENOL Hepatoprotective & Anti-oxidative Extract For Metabolic Syndrome ■ WALNUT POLYPHENOL-P10,P30 (Powder，Food Grade) ■ WALNUT POLYPHENOL-WSP10 (Water-soluble Powder，Food Grade) ■ WALNUT POLYPHENOL-PC10,PC30 （Powder，Cosmetic Grade） ■ WALNUT POLYPHENOL-WSPC10 （Water-soluble Powder，Cosmetic Grade） ■ WALNUT POLYPHENOL-LC （Water-soluble Liquid，Cosmetic Grade） ■ WALNUT SEED OIL （Oil，Food & Cosmetic Grade） ORYZA OIL & FAT CHEMICAL CO., LTD ver. 1.0 HS WALNUT POLYPHENOL ver.1.0 HS WALNUT POLYPHENOL Hepatoprotective & Anti-oxidative Extract For Metabolic Syndrome 1. Introduction Recently, there is an increased awareness on metabolic syndrome – a condition characterized by a group of metabolic risk factors in one person. They include abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, insulin resistance, prothrombotic state & proinflammatory state. The dominant underlying risk factors appear to be abdominal obesity and insulin resistance. In addition, non-alcoholic fatty liver disease (NAFLD) is the most commonly associated “liver” manifestation of metabolic syndrome which can progress to advance liver disease (e.g. cirrhosis) with associated morbidity and mortality. Lifestyle therapies such as weight loss significantly improve all aspects of metabolic syndrome, as well as reducing progression of NAFLD and cardiovascular mortality. Walnut (Juglans regia L. seed) is one the most popular nuts consumed in the world. It is loaded in polyunsaturated fatty acids – linoleic acid (LA), oleic acid and α-linolenic acid (ALA), an ω3 fatty acid. It has been used since ancient times and epidemiological studies have revealed that incorporating walnuts in a healthy diet reduces the risk of cardiovascular diseases. Recent investigations reported that walnut diet improves the function of blood vessels and lower serum cholesterol.
    [Show full text]
  • Diabetic Neuropathy)
    A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR “AKKINI SELATHUMAM” (DIABETIC NEUROPATHY) Dissertation submitted to THE TAMILNADU DR. MGR. MEDICAL UNIVERSITY CHENNAI-32 For the partial fulfillment of the requirements to the Degree of DOCTOR OF MEDICINE (SIDDHA) BRANCH-I DEPARTMENT OF POTHU MARUTHUVAM DEPARTMENT OF POTHU MARUTHUVAM GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. OCTOBER 2019 GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. BONAFIDE CERTIFICATE This is to certify that the dissertation entitled “A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR AKKINI SELATHUMAM (DIABETIC NEUROPATHY)” is abonafide work done by Dr.RAJENDRAM AJANTHAN (Reg. No.321611008) Govt. Siddha Medical College, Palayamkottai - 627 002 in partial fulfilment of the university rules and regulations for award for MD (S) POTHU MARUTHUVAM (BRANCH-I) under my guidance and supervision during the academic year OCTOBER 2016-2019. Supervisor and Guide Prof. Dr.A.MANOHARAN, MD (S),( Ph.D). Head, Department of PothuMaruthuvam, Govt. Siddha Medical College, Palayamkottai. Name and signature of the HOD Name and signature of the Principal Prof. Dr. A.MANOHARAN, MD (S),( Ph.D). Prof. Dr.S.Victoria,MD(S) Dept. of PothuMaruthuvam, Govt. Siddha Medical College Govt. Siddha Medical College, Palayamkottai. Palayamkottai. GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. CERTIFICATE Certified that I have gone through the dissertation entitled “A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR AKKINI SELATHUMAM (DIABETIC NEUROPATHY)” submitted by Dr.RAJENDRAM AJANTHAN (Reg. No.321611008) a student of final year MD(S) Department of Pothu Maruthuvam (Branch-I)of this college and the dissertation work has been carried out by the individual only.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski Et Al
    USOO9421 180B2 (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski et al. (45) Date of Patent: Aug. 23, 2016 (54) ANTIOXIDANT COMPOSITIONS FOR 6,203,817 B1 3/2001 Cormier et al. .............. 424/464 TREATMENT OF INFLAMMATION OR 6,323,232 B1 1 1/2001 Keet al. ............ ... 514,408 6,521,668 B2 2/2003 Anderson et al. ..... 514f679 OXIDATIVE DAMAGE 6,572,882 B1 6/2003 Vercauteren et al. ........ 424/451 6,805,873 B2 10/2004 Gaudout et al. ....... ... 424/401 (71) Applicant: Perio Sciences, LLC, Dallas, TX (US) 7,041,322 B2 5/2006 Gaudout et al. .............. 424/765 7,179,841 B2 2/2007 Zielinski et al. .. ... 514,474 (72) Inventors: Jan Zielinski, Vista, CA (US); Thomas 2003/0069302 A1 4/2003 Zielinski ........ ... 514,452 Russell Moon, Dallas, TX (US); 2004/0037860 A1 2/2004 Maillon ...... ... 424/401 Edward P. Allen, Dallas, TX (US) 2004/0091589 A1 5, 2004 Roy et al. ... 426,265 s s 2004/0224004 A1 1 1/2004 Zielinski ..... ... 424/442 2005/0032882 A1 2/2005 Chen ............................. 514,456 (73) Assignee: Perio Sciences, LLC, Dallas, TX (US) 2005, 0137205 A1 6, 2005 Van Breen ..... 514,252.12 2005. O154054 A1 7/2005 Zielinski et al. ............. 514,474 (*) Notice: Subject to any disclaimer, the term of this 2005/0271692 Al 12/2005 Gervasio-Nugent patent is extended or adjusted under 35 et al. ............................. 424/401 2006/0173065 A1 8/2006 BeZwada ...................... 514,419 U.S.C. 154(b) by 19 days. 2006/O193790 A1 8/2006 Doyle et al.
    [Show full text]
  • Punicalin Alleviates OGD/R-Triggered Cell Injury Via TGF-Β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y
    Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2021, Article ID 6671282, 11 pages https://doi.org/10.1155/2021/6671282 Research Article Punicalin Alleviates OGD/R-Triggered Cell Injury via TGF-β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y Tiansong Yang,1 Qingyong Wang,2 Yuanyuan Qu,2 Yan Liu,1 Chuwen Feng,1 Yulin Wang,2 Weibo Sun,3 Zhongren Sun ,2 and Yulan Zhu4 1First affiliated hospital, Heilongjiang University of Chinese Medicine, Harbin, China 2Heilongjiang University of Chinese Medicine, Harbin, China 3Harbin Medical University, Harbin, China 4Department of Neurology, %e Second Affiliated Hospital of Harbin Medical University, Harbin, China Correspondence should be addressed to Zhongren Sun; [email protected] Received 21 October 2020; Revised 21 October 2020; Accepted 7 January 2021; Published 12 February 2021 Academic Editor: Muhammad Farrukh Nisar Copyright © 2021 Tiansong Yang et al. /is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Purpose. /e research aimed to identify the active component from Punica granatum L. to alleviate ischemia/reperfusion injury and clarify the underlying mechanism of the active component alleviating ischemia/reperfusion injury. Materials and Methods. /e SH-SY5Y cell model of oxygen-glucose deprivation/reoxygenation (OGD/R) was established to simulate the ischemia/ reperfusion injury. According to the strategy of bioassay-guided isolation, the active component of punicalin from Punica granatum L. was identified. Flow cytometry and Western blotting were employed to evaluate the effects of OGD/R and/or punicalin on cell cycle arrest.
    [Show full text]
  • (Hordeum Vulgare L.) Seedlings Via Their
    Ra et al. Appl Biol Chem (2020) 63:38 https://doi.org/10.1186/s13765-020-00519-9 NOTE Open Access Evaluation of antihypertensive polyphenols of barley (Hordeum vulgare L.) seedlings via their efects on angiotensin-converting enzyme (ACE) inhibition Ji‑Eun Ra1, So‑Yeun Woo2, Hui Jin3, Mi Ja Lee2, Hyun Young Kim2, Hyeonmi Ham2, Ill‑Min Chung1 and Woo Duck Seo2* Abstract Angiotensin‑converting enzyme (ACE) is an important therapeutic target in the regulation of high blood pressure. This study was conducted to investigate the alterations in blood pressure associated with ACE inhibition activity of the polyphenols (1–10), including 3‑O‑feruloylquinic acid (1), lutonarin (2), saponarin (3), isoorientin (4), orientin (5), isovitexin (6), isoorientin‑7‑O‑[6‑sinapoyl]‑glucoside (7), isoorientin‑7‑O‑[6‑feruloyl]‑glucoside (8), isovitexin‑7‑O‑ [6‑sinapoyl]‑glucoside (9), and isovitexin‑7‑O‑[6‑feruloyl]‑glucoside (10), isolated from barley seedlings (BS). All the isolated polyphenols exhibited comparable IC50 values of ACE inhibition activity (7.3–43.8 µM) with quercetin (25.2 0.2 µM) as a positive control, and their inhibition kinetic models were identifed as noncompetitive inhibition. ± Especially, compound 4 was revealed to be an outstanding ACE inhibitor (IC50 7.3 0.1 µM, Ki 6.6 0.1 µM). Based on the compound structure–activity relationships, the free hydroxyl groups of =favone± ‑moieties =and glucose± connec‑ tions at the A ring of the favone moieties were important factors for inhibition of ACE. The alcohol extract of BS also 1 demonstrated potent ACE inhibition activity (66.5% 2.2% at 5000 µg mL− ).
    [Show full text]
  • Punica Granatum L
    Research Article Studies on antioxidant activity of red, white, and black pomegranate (Punica granatum L.) peel extract using DPPH radical scavenging method Uswatun Chasanah[1]* 1 Department of Pharmacy, Faculty of Health Science, University of Muhammadiyah Malangg, Malang, East Java, Indonesia * Corresponding Author’s Email: [email protected] ARTICLE INFO ABSTRACT Article History Pomegranate (Punica granatum L.) has high antioxidant activity. In Received September 1, 2020 Indonesia, there are red pomegranate, white pomegranate, and black Revised January 7, 2021 pomegranate. The purpose of this study was to determine the antioxidant Accepted January 14, 2021 activity of red pomegranate peel extract, white pomegranate peel extract, Published February 1, 2021 and black pomegranate peel extract. The extracts prepared by ultrasonic maceration in 96% ethanol, then evaporated until thick extract was Keywords obtained and its antioxidant activity was determined using the DPPH Antioxidant radical scavenging method. This study showed that all pomegranate peel Black pomegranate extract varieties have potent antioxidant activity and the black Red pomegranate pomegranate peel extract has the highest antioxidant power. White pomegranate Peel extract DPPH Doi 10.22219/farmasains.v5i2.13472 1. INTRODUCTION Pomegranate (Punica granatum L.) belongs to the Puricaceae family, a plant originating from the Middle East (Rana, Narzary & Ranade, 2010). All parts of the pomegranate, such as fruit (fruit juice, fruit seeds, peel fruit), leaves, flowers, roots, and bark, have therapeutic effects such as neuroprotective, antioxidant, repair vascular damage, and anti-inflammatory. The clinical application of this plant used in cancers, atherosclerosis, hyperlipidemia, carotid artery stenosis, myocardial perfusion, periodontal disease, bacterial infections, ultraviolet radiation, erectile dysfunction, male infertility, neonatal hypoxic-ischemic brain injury, Alzheimer's disease, and obesity (Jurenka, 2008; Mackler, Heber & Cooper, 2013).
    [Show full text]
  • Infraspecific Variability in the Flavonoid Composition of Artemisia Vulgaris L
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE Acta Bot. Croat. 65 (1), 13–18, 2006 CODEN: ABCRA25 ISSN 0365–0588 Infraspecific variability in the flavonoid composition of Artemisia vulgaris L. MILENA NIKOLOVA* Institute of Botany, Bulgarian Academy of Sciences, 23, Acad. G. Bonchev str. 1113 Sofia, Bulgaria Surface flavonoid profiles in forty populations of Artemisia vulgaris L. (Asteraceae) were analyzed. The major constituents observed in the leaf exudates were methylated flavonoid aglycones based mainly on quercetin. Three infraspecific flavonoid chemotypes were de- termined, the chrysosplenetin (quercetagetin 3,6,7,3’-tetramethyl ether) chemotype, the artemetin (quercetagetin 3,6,7,3’,4’-pentamethyl ether) chemotype and chemotype with- out these two compounds. Most of the populations corresponded to these chemotypes. Key words: Artemisia vulgaris, Asteraceae, flavonoid aglycones, chrysosplenetin, arte- metin, chemotype Introduction Surface flavonoid aglycones are often used in chemotaxonomic studies on Asteraceae at the generic and species level (VALANT-VETSCHERA and WOLLENWEBER 1996, WOLLEN- WEBER et al. 1997, STEVENS et al. 1999). Recent articles showed that a flavonoid pattern couldalsobespecificforachemotype(REP^ÁK et al. 1999, WILLIAMS et al. 2000, MARTONFI et al. 2001, VIEIRA et al. 2003). The species of the genus Artemisia (Asreraceae) have been extensively surveyed for their surface flavonoid constituents (WOLLENWEBER et al. 1989, VALANT-VETSCHERA and WOLLENWEBER 1995, WOLLENWEBER and VALANT-VETSCHERA 1996). Artemisia vulgaris L (Asteraceae) is a perennial polymorphic species, widespread in temperate areas (South Europe, North Africa, North America and Asia). Simple flavonol methyl ethers have been reported for West-European populations (VALANT-VETSCHERA et al.
    [Show full text]
  • A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica Granatum Peel Waste
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2013, Article ID 656172, 10 pages http://dx.doi.org/10.1155/2013/656172 Review Article A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica granatum Peel Waste Sushil Kumar Middha,1 Talambedu Usha,2 and Veena Pande1 1 Department of Biotechnology, Bhimtal Campus, Kumaun University, Nainital, Uttarakhand 263136, India 2 Department of Biotechnology & Biochemistry, Maharani Lakshmi Ammanni College for Women, Bangalore 560012, India Correspondence should be addressed to Veena Pande; veena [email protected] Received 28 December 2012; Revised 25 March 2013; Accepted 25 April 2013 Academic Editor: Edwin L. Cooper Copyright © 2013 Sushil Kumar Middha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Over the past decade, pomegranate (Punica granatum) is entitled as a wonder fruit because of its voluminous pharmacological properties. In 1830, P. g ranatum fruit was first recognized in United States Pharmacopeia; the Philadelphia edition introduced the rind of the fruit, the New York edition the bark of the root and further 1890 edition the stem bark was introduced. There are significant efforts and progress made in establishing thepharmacological mechanisms of peel (pericarp or rind) and the individual constituents responsible for them. This review provides an insight on the phytochemical components that contribute too antihyperglycemic, hepatoprotective, antihyperlipidemic effect, and numerous other effects of wonderful, economic, and eco- friendly pomegranate peel extract (PP). 1. Introduction containing sacs packed with a fleshy, juicy, red or whitish pulp.
    [Show full text]
  • Anti-Candida Targets and Cytotoxicity of Casuarinin Isolated from Plinia Cauliflora Leaves in a Bioactivity-Guided Study
    Molecules 2013, 18, 8095-8108; doi:10.3390/molecules18078095 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Article Anti-Candida Targets and Cytotoxicity of Casuarinin Isolated from Plinia cauliflora Leaves in a Bioactivity-Guided Study Tatiana M. Souza-Moreira 1, Juliana A. Severi 1,†, Keunsook Lee 2, Kanya Preechasuth 2, Emerson Santos 1, Neil A. R. Gow 2, Carol A. Munro 2, Wagner Vilegas 3 and Rosemeire C. L. R. Pietro 1,* 1 Department of Drugs and Medicines, School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Rodovia Araraquara-Jau, km 1, Araraquara, 14801-902, São Paulo, Brazil; E-Mails: [email protected] (T.M.S.M.); [email protected] (J.A.S.); [email protected] (E.S.) 2 Department of Microbiology, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK; E-Mails: [email protected] (K.L.); [email protected] (K.P.); [email protected] (N.A.R.G.); [email protected] (C.A.M.) 3 Department of Organic Chemistry, Institute of Chemistry, UNESP-Univ Estadual Paulista, R. Francisco Degni s/n, Araraquara, 14800-900, São Paulo, Brazil; E-Mail: [email protected] (W.V.) † Nowadays this author is at Department of Pharmacy and Nutrition, Centro de Ciências Agrárias, UFES-Univ Federal do Espírito Santo, Alto Universitário, Guararema, 29500-000, Alegre, ES, Brazil. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +55-16-3301-6965; Fax: +55-16-3301-6990. Received: 27 May 2013; in revised form: 5 July 2013 / Accepted: 5 July 2013 / Published: 9 July 2013 Abstract: In addition to the bio-guided investigation of the antifungal activity of Plinia cauliflora leaves against different Candida species, the major aim of the present study was the search for targets on the fungal cell.
    [Show full text]
  • Absorption of Dietary Licorice Isoflavan Glabridin to Blood Circulation in Rats
    J Nutr Sci Vitaminol, 53, 358–365, 2007 Absorption of Dietary Licorice Isoflavan Glabridin to Blood Circulation in Rats Chinatsu ITO1, Naomi OI1, Takashi HASHIMOTO1, Hideo NAKABAYASHI1, Fumiki AOKI2, Yuji TOMINAGA3, Shinichi YOKOTA3, Kazunori HOSOE4 and Kazuki KANAZAWA1,* 1Laboratory of Food and Nutritional Chemistry, Graduate School of Agriculture, Kobe University, Rokkodai, Nada-ku, Kobe 657–8501, Japan 2Functional Food Ingredients Division, Kaneka Corporation, 3–2–4 Nakanoshima, Kita-ku, Osaka 530–8288, Japan 3Functional Food Ingredients Division, and 4Life Science Research Laboratories, Life Science RD Center Kaneka Corporation, 18 Miyamae-machi, Takasago, Hyogo 676–8688, Japan (Received February 19, 2007) Summary Bioavailability of glabridin was elucidated to show that this compound is one of the active components in the traditional medicine licorice. Using a model of intestinal absorption, Caco-2 cell monolayer, incorporation of glabridin was examined. Glabridin was easily incorporated into the cells and released to the basolateral side at a permeability coef- ficient of 1.70Ϯ0.16 cm/sϫ105. The released glabridin was the aglycone form and not a conjugated form. Then, 10 mg (30 ␮mol)/kg body weight of standard chemical glabridin and licorice flavonoid oil (LFO) containing 10 mg/kg body weight of glabridin were adminis- tered orally to rats, and the blood concentrations of glabridin was determined. Glabridin showed a maximum concentration 1 h after the dose, of 87 nmol/L for standard glabridin and 145 nmol/L for LFO glabridin, and decreased gradually over 24 h after the dose. The level of incorporation into the liver was about 0.43% of the dosed amount 2 h after the dose.
    [Show full text]